New Human Embryonic Stem-Cell Lines — More Is Better
- 25 March 2004
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (13) , 1275-1276
- https://doi.org/10.1056/nejmp048045
Abstract
It is rare that a field of scientific research can simultaneously represent a domain of fundamental discovery in human biology and potentially have major effects on human health and the quality of life. Human embryonic stem cells serve not only as a resource for basic research, but also as the starting material for the development of cell-based therapies. Formidable scientific challenges face those who aim to develop cell-based therapies. It will take the efforts of many scientists and clinicians in a variety of disciplines to bring this endeavor to fruition. Of immediate importance and concern is whether or not we have sufficient starting material for the initial phases of this research.Keywords
This publication has 6 references indexed in Scilit:
- Derivation of Embryonic Stem-Cell Lines from Human BlastocystsNew England Journal of Medicine, 2004
- Safety issues in cell-based intervention trialsFertility and Sterility, 2003
- Setting Standards for Human Embryonic Stem CellsScience, 2003
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.Proceedings of the National Academy of Sciences, 1981
- Establishment in culture of pluripotential cells from mouse embryosNature, 1981